Uroplasty and Vision-Sciences Complete Merger Creates New Medical Device Company: Cogentix Medical, Inc. Cogentix shares will begin trading under symbol CGNT on April 1, 2015 PR...
Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement PR Newswire MINNEAPOLIS and ORANGEBURG, N.Y., March 30, 2015 MINNEAPOLIS andย ORANGEBURG, N.Y., March 30, 2015 /PRNewswire/...
Uroplasty to Host Investor Meeting at Corporate Headquarters March 12th Event to Feature Urologist Perspective on the Use of Uroplasty and Vision-Sciences Product Lines PR Newswire MINNEAPOLIS...
Uroplasty to Participate in the 27th Annual ROTH Conference PR Newswire MINNEAPOLIS, Feb. 27, 2015 MINNEAPOLIS, Feb. 27, 2015 /PRNewswire/ --ย Uroplasty, Inc.ย (NASDAQ: UPI), a medical device...
Uroplasty Announces Positive Coverage Decision For Percutaneous Tibial Nerve Stimulation By Cigna PR Newswire MINNEAPOLIS, Feb. 24, 2015 MINNEAPOLIS, Feb. 24, 2015 /PRNewswire/ --ย Uroplasty...
Uroplasty Reports Record Revenue in Fiscal Third Quarter ~ Global Urgent PC Sales Up 14.5% ~~ Proposed Merger with Vision-Sciences to Expand Innovation in Product Portfolio PR...
NEW YORK, Jan. 16, 2015 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies shareholders of Uroplasty, Inc. ("Uroplasty" or "the Company") (Nasdaq:UPI) of claims of breaches of fiduciary duty and...
Uroplasty To Announce Third Quarter Fiscal Year 2015 Financial Results On January 22, 2015 PR Newswire MINNEAPOLIS, Jan. 14, 2015 MINNEAPOLIS, Jan. 14, 2015 /PRNewswire/ -- Uroplasty, Inc...
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Uroplasty, Inc. (NasdaqCM:UPI) (โUroplastyโ) in connection with the sale of the Company...
Lifshitz & Miller Law Firm Announces Investigation of Caesars Acquisition Company, Imperial Holdings, Inc., Peerless Systems Corporation, Roka Bioscience, Inc., RCS Capital Corporation and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.